NEW YORK (GenomeWeb News) – Women's health diagnostics company Inex Innovations Exchange announced today a partnership with BGI to create a next-generation sequencing facility in Singapore to offer molecular genetic tests.

The first test to be offered will be iGeneScreen, a non-invasive test developed by BGI to detect fetal chromosomal abnormalities. Using a 5 milliliter blood sample from expectant mothers at 12 weeks or later into their pregnancies, the test analyzes fetal DNA in maternal blood for trisomies 21, 18, and 13.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.